1.Trend Analysis of Research Articles Published in the Korean Journal of Women Health Nursing from 2013 to 2017.
Young Jin LEE ; Seo Yun KIM ; Saem Yi KANG ; Yoo Jeong KANG ; Lan JIN ; Hee Yoen JUNG ; Hae Won KIM
Korean Journal of Women Health Nursing 2018;24(1):90-103
PURPOSE: To analyze articles published in the Korean Journal of Women Health Nursing from 2013 to 2017 to determine the latest research trends and understand how 2013 Korea Women's Health Statistics were reflected in journal articles. METHODS: A total of 130 studies were analyzed. Research design, types of research, research framework, research subjects, characteristics of quantitative research, characteristics of qualitative research, and keywords were analyzed using a structured analysis format. RESULTS: Quantitative and qualitative research accounted for 83.8% and 13% of these 130 studies analyzed, respectively. Non-experimental and experimental research accounted for 70.7% and 13.1% of these studies, respectively. The most frequent study subjects were childbearing women (62.8%), including college students, mothers, and adults. A total of 69.1% of non-experimental research and 88.2% of experimental research used convenience sampling. Questionnaires were most frequently used for data collection. The most frequent keyword domain involved health-related concepts (41%) among nine domains and the most frequently used keyword was “women.” CONCLUSION: This study suggest that further experimental research should be conducted in the future. Also, adolescent and the elderly women should be focused on as subjects in future studies based on results of 2013 Korean Women's Health Statistics.
Adolescent
;
Adult
;
Aged
;
Data Collection
;
Female
;
Humans
;
Korea
;
Mothers
;
Nursing*
;
Qualitative Research
;
Research Design
;
Research Subjects
;
Women's Health
2.Nuclear Expression of Hepatitis B Virus X Protein Is Associated with Recurrence of Early-Stage Hepatocellular Carcinomas: Role of Viral Protein in Tumor Recurrence.
Jing JIN ; Hae Yoen JUNG ; Kyu Ho LEE ; Nam Joon YI ; Kyung Suk SUH ; Ja June JANG ; Kyoung Bun LEE
Journal of Pathology and Translational Medicine 2016;50(3):181-189
BACKGROUND: Hepatitis B virus (HBV) plays well-known roles in tumorigenesis of hepatocellular carcinoma (HCC) in infected patients. However, HBV-associated protein status in tumor tissues and the relevance to tumor behavior has not been reported. Our study aimed to examine the expression of HBV-associated proteins in HCC and adjacent nontumorous tissue and their clinicopathologic implication in HCC patients. METHODS: HBV surface antigen (HBsAg), HBV core antigen (HBcAg), and HBV X protein (HBx) were assessed in 328 HBV-associated HCCs and in 155 matched nontumorous tissues by immunohistochemistry staining. RESULTS: The positive rates of HBsAg and cytoplasmic HBx staining in tumor tissue were lower than those in nontumorous tissue (7.3% vs. 57.4%, p < .001; 43.4% vs. 81.3%, p < .001). Conversely, nuclear HBx was detected more frequently in tumors than in nontumorous tissue (52.1% vs. 30.3%, p < .001). HCCs expressing HBsAg, HBcAg, or cytoplasmic HBx had smaller size; lower Edmondson-Steiner (ES) nuclear grade, pT stage, and serum alpha-fetoprotein, and less angioinvasion than HCCs not expressing HBV-associated proteins. Exceptionally, nuclear HBx-positive HCCs showed higher ES nuclear grade and more frequent large-vessel invasion than did nuclear HBx-negative HCCs. In survival analysis, only nuclear HBx-positive HCCs had shorter disease-free survival than nuclear HBx-negative HCCs in pT1 and ES nuclear grade 1-2 HCC subgroup (median, 126 months vs. 35 months; p = .015). CONCLUSIONS: Our data confirmed that expression of normal HBV-associated proteins generally decreases in tumor cells in comparison to nontumorous hepatocytes, with the exception of nuclear HBx, which suggests that nuclear HBx plays a role in recurrence of well-differentiated and early-stage HCCs.
alpha-Fetoproteins
;
Antigens, Surface
;
Carcinogenesis
;
Carcinoma, Hepatocellular*
;
Cytoplasm
;
Disease-Free Survival
;
Hepatitis B Core Antigens
;
Hepatitis B Surface Antigens
;
Hepatitis B virus*
;
Hepatitis B*
;
Hepatitis*
;
Hepatocytes
;
Humans
;
Immunohistochemistry
;
Recurrence*
3.Low-Grade Fibromyxoid Sarcoma of the Malar Area.
Jun Ho LEE ; Hwan Jun CHOI ; Hae Yoen JUNG
Archives of Plastic Surgery 2016;43(1):110-112
No abstract available.
Sarcoma*
4.Loss of FAT Atypical Cadherin 4 Expression Is Associated with High Pathologic T Stage in Radically Resected Gastric Cancer.
Hae Yoen JUNG ; Hyundeuk CHO ; Mee Hye OH ; Ji Hye LEE ; Hyun Ju LEE ; Si Hyong JANG ; Moon Soo LEE
Journal of Gastric Cancer 2015;15(1):39-45
PURPOSE: Recent studies have revealed recurrent alterations in the cell adhesion gene FAT4, a candidate tumor suppressor gene, in cancer. FAT atypical cadherin 4 (FAT4) is a transmembrane receptor involved in the Hippo signaling pathway, which is involved in the control of organ size. Here, we investigated the loss of FAT4 expression and its association with clinicopathological risk factors in gastric cancer. MATERIALS AND METHODS: We assessed the expression of FAT4 by using immunohistochemistry on three tissue microarrays containing samples from 136 gastric cancer cases, radically resected in the Soonchunhyang University Cheonan Hospital between July 2006 and June 2008. Cytoplasmic immunoexpression of FAT4 was semi-quantitatively scored using the H-score system. An H-score of > or =10 was considered positive for FAT4 expression. RESULTS: Variable cytoplasmic expressions of FAT4 were observed in gastric cancers, with 33 cases (24.3%) showing loss of expression (H-score <10). Loss of FAT4 expression was associated with an increased rate of perineural invasion (H-score <10 vs. > or =10, 36.4% vs. 16.5%, P=0.015), high pathologic T stage (P=0.015), high tumor-node-metastasis stage (P=0.017), and reduced disease-free survival time (H-score <10 vs. > or =10, mean survival 62.7+/-7.3 months vs. 79.1+/-3.1 months, P=0.025). However, no association was found between the loss of FAT4 expression and tumor size, gross type, histologic subtype, Lauren classification, lymphovascular invasion, or overall survival. CONCLUSIONS: Loss of FAT4 expression appears to be associated with invasiveness in gastric cancer.
Cell Adhesion
;
Chungcheongnam-do
;
Classification
;
Cytoplasm
;
Disease-Free Survival
;
Genes, Tumor Suppressor
;
Immunohistochemistry
;
Organ Size
;
Risk Factors
;
Stomach Neoplasms*
5.A Rare Case of Primary Tubular Adenocarcinoma of the Thymus, Enteric Immunophenotype: A Case Study and Review of the Literature.
Hae Yoen JUNG ; Hyundeuk CHO ; Jin Haeng CHUNG ; Sang Byoung BAE ; Ji Hye LEE ; Hyun Ju LEE ; Si Hyong JANG ; Mee Hye OH
Journal of Pathology and Translational Medicine 2015;49(4):331-334
Thymic carcinomas are uncommon malignant tumors, and thymic adenocarcinomas are extremely rare. Here, we describe a case of primary thymic adenocarcinoma in a 59-year-old woman. Histological examination of the tumor revealed tubular morphology with expression of cytokeratin 20 and caudal-type homeobox 2 according to immunohistochemistry, suggesting enteric features. Extensive clinical and radiological studies excluded the possibility of an extrathymic primary tumor. A review of the literature revealed only two global cases of primary tubular adenocarcinomas of the thymus with enteric immunophenotype.
Adenocarcinoma*
;
Female
;
Genes, Homeobox
;
Humans
;
Immunohistochemistry
;
Keratin-20
;
Middle Aged
;
Thymoma
;
Thymus Gland*
6.Loss of ARID1A Expression in Gastric Cancer: Correlation with Mismatch Repair Deficiency and Clinicopathologic Features.
Kyung Ju KIM ; Hae Yoen JUNG ; Mee Hye OH ; Hyundeuk CHO ; Ji Hye LEE ; Hyun Ju LEE ; Si Hyong JANG ; Moon Soo LEE
Journal of Gastric Cancer 2015;15(3):201-208
PURPOSE: The AT-rich interactive domain 1A (ARID1A) gene encodes BRG1-associated factor 250a, a component of the SWItch/Sucrose NonFermentable chromatin remodeling complex, which is considered a tumor suppressor in many tumors. We aimed to investigate the prognostic significance of ARID1A expression in gastric cancers and explore its relationship with clinicopathologic parameters such as mismatch repair protein expression. MATERIALS AND METHODS: Four tissue microarrays were constructed from 191 resected specimens obtained at Soonchunhyang University Cheonan Hospital from 2006 to 2008. Nuclear expression of ARID1A was semiquantitatively assessed and binarized into retained and lost expression. RESULTS: Loss of ARID1A expression was observed in 62 cases (32.5%). This was associated with more frequent vascular invasion (P=0.019) and location in the upper third of the stomach (P=0.001), and trended toward more poorly differentiated subtypes (P=0.054). ARID1A loss was significantly associated with the mismatch repair-deficient phenotype (P=0.003). ARID1A loss showed a statistically significant correlation with loss of MLH1 (P=0.001) but not MSH2 expression (P=1.000). Kaplan-Meier survival analysis showed no statistically significant difference in overall survival; however, patients with retained ARID1A expression tended to have better overall survival than those with loss of ARID1A expression (P=0.053). In both mismatch repair-deficient and mismatch repair-proficient groups, survival analysis showed no differences related to ARID1A expression status. CONCLUSIONS: Our results demonstrated that loss of ARID1A expression is closely associated with the mismatch repair-deficient phenotype, especially in sporadic microsatellite instability-high gastric cancers.
Chromatin Assembly and Disassembly
;
Chungcheongnam-do
;
DNA Mismatch Repair*
;
Humans
;
Microsatellite Instability
;
Microsatellite Repeats
;
Phenotype
;
Stomach
;
Stomach Neoplasms*
7.Loss of Tumor Suppressor ARID1A Protein Expression Correlates with Poor Prognosis in Patients with Primary Breast Cancer.
Hyun Deuk CHO ; Jong Eun LEE ; Hae Yoen JUNG ; Mee Hye OH ; Ji Hye LEE ; Si Hyong JANG ; Kyung Ju KIM ; Sun Wook HAN ; Sung Yong KIM ; Han Jo KIM ; Sang Byung BAE ; Hyun Ju LEE
Journal of Breast Cancer 2015;18(4):339-346
PURPOSE: Somatic mutations of the chromatin remodeling AT-rich interactive domain 1A (SWI-like) gene (ARID1A) have been identified in many human cancers, including breast cancer. The purpose of this study was to evaluate the nuclear expression of ARID1A in breast cancers by immunohistochemistry (IHC) and to correlate the findings to clinicopathologic variables including prognostic significance. METHODS: IHC was performed on tissue microarrays of 476 cases of breast cancer. Associations between ARID1A expression and clinicopathologic characteristics and molecular subtype were retrospectively analyzed. RESULTS: Low expression of ARID1A was found in 339 of 476 (71.2%) cases. Low expression of ARID1A significantly correlated with positive lymph node metastasis (p=0.027), advanced pathologic stage (p=0.001), low Ki-67 labeling index (p=0.003), and negative p53 expression (p=0.017). The ARID1A low expression group had significantly shorter disease-free and overall survival than the ARID1A high expression group (p<0.001 and p<0.001, respectively). Multivariate analysis demonstrated that low expression of ARID1A was a significant independent predictive factor for poor disease-free and overall survival in patients with breast cancer (disease-free survival: hazard ratio, 0.38, 95% confidence interval [CI], 0.20-0.73, p=0.004; overall survival: hazard ratio, 0.11, 95% CI, 0.03-0.46, p=0.003). In patients with luminal A type disease, patients with low ARID1A expression had significantly shorter disease-free and overall survival rates than patients with high ARID1A expression (p=0.022 and p=0.018, respectively). CONCLUSION: Low expression of ARID1A is an independent prognostic factor for disease-free and overall survival in breast cancer patients and may be associated with luminal A type disease. Although the biologic function of ARID1A in breast cancer remains unknown, low expression of ARID1A can provide valuable prognostic information.
Breast Neoplasms*
;
Breast*
;
Chromatin Assembly and Disassembly
;
Humans
;
Immunohistochemistry
;
Lymph Nodes
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Phenobarbital
;
Prognosis*
;
Retrospective Studies
;
Survival Rate
8.Mediastinal Glomus Tumor: A Case Report and Literature Review.
Si Hyong JANG ; Hyun Deuk CHO ; Ji Hye LEE ; Hyun Ju LEE ; Hae Yoen JUNG ; Kyung Ju KIM ; Sung Sik CHO ; Mee Hye OH
Journal of Pathology and Translational Medicine 2015;49(6):520-524
A glomus tumor in the mediastinum is very uncommon, and only five cases have been reported in the English literature. We recently encountered a 21-year-old woman with an asymptomatic mediastinal mass that measured 5.3 x 4.0 cm. Surgical excision was performed, and the tumor was finally diagnosed as mediastinal glomus tumor with an uncertain malignant potential. After reviewing this case and previous reports, we analyzed the clinicopathologic features associated with progression of such a tumor.
Female
;
Glomus Tumor*
;
Humans
;
Mediastinum
;
Young Adult
9.A Case of Thymic Carcinoma with Behcet's Disease Combined with Immunoglobulin A Nephropathy.
Se Hee PARK ; Jung Ho KIM ; Jung Yoen LEE ; Sug Kyun SHIN ; Yong Kook HONG ; Jeong Hae KIE ; Du Yong KANG ; Chan Hee LEE
Journal of Rheumatic Diseases 2015;22(2):118-122
Behcet's disease is a systemic inflammatory disorder of unknown etiology, characterized by recurrent oral aphthous ulcers, genital ulcers, uveitis, and skin lesions. Renal involvement is rare in patients with Behcet's disease particularly immunoglobulin A (IgA) nephropathy. Other autoimmune diseases have been associated with increased risk of malignancy, but not Behcet's disease. Some cases of Behcet's disease accompanied by bladder cancer, thyroid cancer, stomach cancer, or hematologic malignancies have been reported. However, to the best of our knowledge, co-occurrence of Behcet's diseases with thymic carcinoma has not yet been reported. We experienced a 49-year-old male patient who had been treated for Behcet disease and IgA nephropathy, who presented with a large mediastinal mass on chest x-ray. After thymectomy, he was diagnosed with thymic carcinoma with complete resection.
Autoimmune Diseases
;
Behcet Syndrome
;
Glomerulonephritis, IGA*
;
Hematologic Neoplasms
;
Humans
;
Immunoglobulin A
;
Male
;
Middle Aged
;
Skin
;
Stomach Neoplasms
;
Stomatitis, Aphthous
;
Thorax
;
Thymectomy
;
Thymoma*
;
Thyroid Neoplasms
;
Ulcer
;
Urinary Bladder Neoplasms
;
Uveitis
10.Factors associated with Postpartum Depression and Its Influence on Maternal Identity.
Korean Journal of Women Health Nursing 2014;20(1):29-37
PURPOSE: This study aimed to examine the factors associated with postpartum depression and its influence on maternal identity of postpartum women. METHODS: Research design was a cross sectional descriptive study with a total of 89 women within the six month postpartum period. Associations of eating habits, overall sleep quality and other factors with postpartum depression utilizing the Korean Beck Depression Inventory (K-BDI) were done. The influence of postpartum depression on maternal identity was analyzed. Variables yielding significant associations (p<.05) were included in an adjusted logistic regression and a stepwise multiple regression. RESULTS: Mean scores of postpartum depression was 9.42+/-6.08 and 31.5% (n=28) for mild depression, 11.2% (n=10) was moderate and 4.5% (n=4) was severe depression on the K-BDI scale. Perceived health status and overall sleep quality were predictors of postpartum depression. Postpartum depression and the husband's love were predictors of maternal identity. CONCLUSION: Awareness of poor health perception and sleep quality will be helpful to detect for postpartum depression. Strategies to increase maternal identity during the postpartum period would be tailored by level of depression.
Depression
;
Depression, Postpartum*
;
Eating
;
Female
;
Humans
;
Logistic Models
;
Love
;
Postpartum Period*
;
Research Design

Result Analysis
Print
Save
E-mail